Company Overview of LaraPharm Ltd.
LaraPharm Ltd. engages in the development, manufacture, and distribution of prescription pharmaceuticals. It focuses on developing a portfolio of cannabis-based drugs for the treatment of various diseases, including migraine, post traumatic stress disorder, neuropathic pain, cancer pain, fibromyalgia pain, epilepsy, cardiovascular disease, chemotherapy disease and symptoms, multiple sclerosis, rheumatoid arthritis, gastro-inflammatory, diabetes, nausea vomiting, glaucoma, Parkinson and Huntington diseases, Tourette syndrome, and insomnia sleep disorder. The company is based in Kadima, Israel.
972 9 891 1667
Key Executives for LaraPharm Ltd.
Similar Private Companies By Industry
|Abital Pharma Pipelines Ltd.||Middle East/Africa|
|Active PX Ltd.||Middle East/Africa|
|Advanced Inhalation Technology Ltd.||Middle East/Africa|
|Alvit LCS Pharma Ltd||Middle East/Africa|
|Angio B Ltd.||Middle East/Africa|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact LaraPharm Ltd., please visit www.larapharm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.